Description

SS-31 Research Grade Compound Handbook Product Overview

SS-31 (Elamipramide) is a small molecule peptide targeting mitochondria, which selectively binds to cardiolipin (the core component of mitochondrial inner membrane), inhibits reactive oxygen species (ROS) generation (reducing by 70%), and stabilizes electron transport chain function (increasing ATP synthesis efficiency by 45%), thereby improving energy metabolism and cell survival. It can repair structural abnormalities in cardiac phospholipids (acyl chain saturation increased by 30%), prevent the initiation of cell apoptosis, and activate antioxidant/metabolic regulatory pathways (PGC-1 α increased by 2 times), showing broad-spectrum therapeutic potential for mitochondrial related diseases such as Alzheimer’s disease (A β deposition reduced by 55%), non-alcoholic fatty liver disease (lipid droplet area decreased by 62%), and heart failure (ejection fraction improved by 25%). As the first peptide therapy targeting mitochondrial myopathy, phase II clinical trials have confirmed that it can significantly improve patients’ motor ability (6-minute walking distance+28%), providing a new strategy for precise intervention in neuromuscular and metabolic diseases.

main features
·    High purity: HPLC verification purity ≥ 99%
·    Research focus: SS-31 improves ATP synthesis efficiency by repairing mitochondrial function and inhibiting the release of inflammatory factors, significantly reducing oxidative stress-related pathological damage such as Alzheimer’s disease, Parkinson’s disease, cardiovascular disease, and metabolic diseases.
·    Appearance: Peptide in freeze-dried (powder) form
·    Packaging specification: 10mg standard packaging (can be customized according to requirements)
·    Cold chain transportation: Ensure temperature throughout the entire process (-20 ℃)

Disclaimer: The waiver shall ensure that:
Comply with the laboratory’s “Regulations on the Management of Hazardous Chemicals” and local regulations
Established compound lifecycle tracking system
Any consequences resulting from authorized resale or non scientific use shall be borne by the user themselves